Abstract
Shigella flexneri serotype 1b is among the most prominent serotypes in developing countries, followed by serotype 2a. However, only limited data is available on the global phenotypic and genotypic characteristics of S. flexneri 1b. In the present study, 40 S. flexneri 1b isolates from different regions of China were confirmed by serotyping and biochemical characterization. Antimicrobial susceptibility testing showed that 85% of these isolates were multidrug-resistant strains and antibiotic susceptibility profiles varied between geographical locations. Strains from Yunnan were far more resistant than those from Xinjiang, while only one strain from Shanghai was resistant to ceftazidime and aztreonam. Fifteen cephalosporin resistant isolates were identified in this study. ESBL genes (bla SHV, bla TEM, bla OXA, and bla CTX-M) and ampC genes (bla MOX, bla FOX, bla MIR(ACT-1), bla DHA, bla CIT and bla ACC) were subsequently detected among the 15 isolates. The results showed that these strains were positive only for bla TEM, bla OXA, bla CTX-M, intI1, and intI2. Furthermore, pulsed-field gel electrophoresis (PFGE) analysis showed that the 40 isolates formed different profiles, and the PFGE patterns of Xinjiang isolates were distinct from Yunnan and Shanghai isolates by one obvious, large, missing band. In summary, similarities in resistance patterns were observed in strains with the same PFGE pattern. Overall, the results supported the need for more prudent selection and use of antibiotics in China. We suggest that antibiotic susceptibility testing should be performed at the start of an outbreak, and antibiotic use should be restricted to severe Shigella cases, based on resistance pattern variations observed in different regions. The data obtained in the current study might help to develop a strategy for the treatment of infections caused by S. flexneri 1b in China.
Highlights
ObjectivesThe objective of the present study was to evaluate the antimicrobial resistance profiles of S. flexneri 1b isolates from different regions of China, and guide the selection of the most effective antimicrobial agents for shigellosis treatment
Shigella, the causative agent of human shigellosis, is a significant public health burden
We isolated and identified 40 S. flexneri 1b isolates from patients with either diarrhea or dysentery over the period from 2005 to 2013
Summary
The objective of the present study was to evaluate the antimicrobial resistance profiles of S. flexneri 1b isolates from different regions of China, and guide the selection of the most effective antimicrobial agents for shigellosis treatment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.